These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6889765)

  • 1. Pavlovian conditional tolerance to haloperidol catalepsy: evidence of dynamic adaptation in the dopaminergic system.
    Poulos CX; Hinson R
    Science; 1982 Oct; 218(4571):491-2. PubMed ID: 6889765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ; Korf J
    Psychopharmacology (Berl); 1986; 90(1):54-7. PubMed ID: 3094062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-trial dopaminergic modulation of conditioned catalepsy: A single apomorphine induced increase/decrease in dopaminergic activation immediately following a conditioned catalepsy response can reverse/enhance a haloperidol conditioned and sensitized catalepsy response.
    Oliveira LR; Dias FRC; Santos BG; Silva JLL; Carey RJ; Carrera MP
    Behav Brain Res; 2016 Sep; 311():87-98. PubMed ID: 27173428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional tolerance to haloperidol-induced catalepsy: striatal dopamine receptor supersensitivity is a possible explanation.
    Hoffman DC; Beninger RJ
    Psychopharmacology (Berl); 1988; 95(1):142-5. PubMed ID: 3133695
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors.
    Sanberg PR
    Nature; 1980 Apr; 284(5755):472-3. PubMed ID: 7189016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditioned tolerance to haloperidol- and droperidol-induced catalepsy.
    Nowak K; Welsch-Kunze S; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):385-91. PubMed ID: 3405313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
    Banasikowski TJ; Beninger RJ
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J; Pietraszek M; Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of substantia nigra pars reticulata neurons in the expression of neuroleptic-induced catalepsy.
    Morelli M; Porceddu ML; Imperato A; Di Chiara G
    Brain Res; 1981 Aug; 217(2):375-9. PubMed ID: 6972799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theophylline reverses haloperidol-induced catalepsy in the rat. Possible relevance to the pharmacological treatment of psychosis.
    Casas M; Ferre S; Guix T; Jane F
    Biol Psychiatry; 1988 Oct; 24(6):642-8. PubMed ID: 3167148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of haloperidol-induced catalepsy by dopamine agonists: possible involvement of central 5-hydroxytryptamine.
    Carter CJ; Pycock CJ
    Pharmacol Biochem Behav; 1979 Apr; 10(4):475-80. PubMed ID: 572550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice.
    Viyoch J; Ohdo S; Yukawa E; Higuchi S
    J Pharmacol Exp Ther; 2001 Sep; 298(3):964-9. PubMed ID: 11504791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors.
    Banasikowski TJ; Beninger RJ
    Int J Neuropsychopharmacol; 2012 Nov; 15(10):1525-34. PubMed ID: 22093169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The characteristics of the minute fluctuations in haloperidol-induced catalepsy and the contribution of different sections of the striatum to their formation in rats].
    Arushanian EB; Popov AV; Popova AP
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(3):573-82. PubMed ID: 1323183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of different types of cortical lesions on drug-induced catalepsy in rats: a pharmacological analysis.
    Worms P; Willigens MT; Continsouza-Blanc D; Lloyd KG
    Eur J Pharmacol; 1985 Jul; 113(1):53-9. PubMed ID: 2864264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic mechanisms underlying catalepsy, fear and anxiety: do they interact?
    Colombo AC; de Oliveira AR; Reimer AE; Brandão ML
    Behav Brain Res; 2013 Nov; 257():201-7. PubMed ID: 24120401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cataleptogenic effect of haloperidol, chlorpromazine and morphine in developing rats.
    Brus R; Krzemiński T; Piguła J
    Pol J Pharmacol Pharm; 1983; 35(5):377-82. PubMed ID: 6686676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance of haloperidol catalepsy.
    Ezrin-Waters C; Seeman P
    Eur J Pharmacol; 1977 Feb; 41(3):321-7. PubMed ID: 556989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.